Shasun Pharmaceuticals, Chennai, India an integrated pharmaceutical company through its wholly owned subsidiary, SVADS Holdings, Switzerland (SVADS) has acquired the global rights from ScolrPharma, USA (Scolr), to develop and commercialize Ibuprofen 12 hour Extended Release OTC tablets (Asset) as well as the associated Controlled Release Technology (CDT) along with global rights of Nuprin trademark, a well known brand in Analgesics. The Asset, having completed a successful Phase III in the US is a differentiated long acting NSAIDS in the Multi Billion Dollar global OTC analgesic market.
For more information ✆ - 0731-6642300 or Visit
http://ift.tt/1doLhaI 
04:58
Unknown
Posted in: Indian Market Tips
0 comments:
Post a Comment